HIGHLIGHTS
- who: Suree Lekawanvijit et al. from the Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia have published the article: Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non- Dialysable Uremic Toxin, Indoxyl Sulfate, in the Journal: (JOURNAL) of July/19,/2012
- what: The aim of the present in_vivo study was to test this hypothesis by determining whether IS-reducing therapy may have beneficial effects on the cardiac manifestations of CKD. The aim of this study was to test the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.